Abstract
Mouse hepatitis virus type 3 infection leads to various types of evolution according to strain, age and immune status of animals-1, 2. Three types of viral sensitivity were observed: resistance, full susceptibility and semisusceptibility. The latter is characterized by a chronic disease with occurrence of paralysis, immunodepression, and viral persistency since MHV3 can be recovered during the first three months postinfection in most animals from brain, liver, spleen and lymph nodes1. During the first four days of infection, virus was recovered from the liver of resistant as well as susceptible strain mice. In resistant A/J strain mice, viral titers were consistently low whereas titers greater than 104 were always found in susceptible C57BL/6 animals. In the resistant mouse strain, virus was cleared from liver, brain and serum within seven days. In contrast, virus continued to replicate until death in susceptible animals. Immunosuppressive treatment, however, can abogate the resistance displayed by adult A/J mice, leading to an acute disease and to death. Protection of susceptible newborn mice against MHV3 infection requires the transfer of several cell populations originating from syngenic adult donors: adherent spleen cells, T lymphocytes and a third population present in the non-adherent spleen cell fraction as well as in peritoneal exudate and in bone marrow cells2, 3. Resistance to the acute disease was also correlated with viral replication in hepatocytes4, in embryonic fibroblasts5 and in peritoneal exudate cells2, 6, 7. Recent work suggested that at least two complementary mechanisms were required to confer resistance to MHV3: resistance genes operating at the macrophage level and cells capable to elicit an efficient immune response8.
Chapter PDF
References
C. Le Prévost, E. Levy-Leblond, J.L. Virelizier, and J.M. Dupuy, Immunopathology of mouse hepatitis virus type 3 infection. I. Clinical and virological observation of a persistent 3 infection, J. Immunol., 115: 640 (1975).
J.M. Dupuy, E. Levy-Leblond, and C. Le Prévost, Immunopathology of mouse hepatitis virus type 3 infection. II. Effect of immunosuppression in resistant mice, J. Immunol., 114-226 (1975).
M. Tardieu, C. Hery, and J.M. Dupuy, Neonatal susceptibility to MHV3 infection in mice. II. Role of natural effector marrow cells in transfer of resistance, J. Immunol., 124: 418 (1980).
H. Arnheiter, T. Baechi, and O. Haller, Adult mouse hepatocytes in primary monolayer culture express genetic resistance to mouse hepatitis virus type 3, J. Immunol., 129: 1275 (1982).
L.M. Lamontagne and J.M. Dupuy, Natural resistance of mice to mouse hepatitis virus type 3 infection is expressed in embryonic fibroblast cells, J. Gen. Virol., 65: 1165 (1984).
J.L. Virelizier and A.C. Allison, Correlation of persistent mouse hepatitis virus (MHV3) infection with its effect on mouse macrophage cultures, Arch. Virol., 50: 279 (1976).
M.R. MacNaughton and S. Patterson, Mouse hepatitis virus strain 3 infection of C5, A/S and A/J strain mice and their macrophages, Arch. Virol., 66: 71 (1980).
C. Dupuy, D. Lafforet-Cresteil, and J.M. Dupuy, Genetic study of MHV3 infection in mice: in vitro replication of virus in macrophages, in: “Genetic control of natural resistance to infection and malignancy”, E. Skamene, P.A.L. Kongshavn and M. Landry, eds, Academic Press, New York (1980).
L.M. Lamontagne and J.M. Dupuy, Persistent infection with mouse hepatitis virus 3 in mouse lymphoid cell lines, Infect. & Immun., 44: 716 (1984).
H. Towbin, T. Staehlin, and J. Gordon, Electrophoretic transfer or proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl. Acad. Sci USA, 76: 4350 (1979).
J.O. Fleming, S.A. Stohlman, R.C. Harmon, M.M.C. Lai, J.A. Frelinger and L.P. Weiner, Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV4) virus, Virology, 131: 296 (1983).
M.M.C. Lai and S.A. Stohlman, Genome structure of mouse hepatitis virus: comparative analysis by oligo nucleotide mapping, in: “Biochemistry and biology of coronaviruses”, V. Ter Meulen, S. Siddell and H. Wege, eds, Plenum Press, New York (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Lamontagne, L., Dupuy, J.M. (1987). Characterization of a Non-Pathogenic MHV3 Variant Derived from a Persistently Infected Lymphoid Cell Line. In: Lai, M.M.C., Stohlman, S.A. (eds) Coronaviruses. Advances in Experimental Medicine and Biology, vol 218. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1280-2_30
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1280-2_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1282-6
Online ISBN: 978-1-4684-1280-2
eBook Packages: Springer Book Archive